Extended antibiotics do not reduce infection or reconstruction failure after postmastectomy breast reconstruction.

Routine testing for ESR1 mutations should occur upon recurrence or progression of HR+, HER2- metastatic breast cancer, a guideline suggests.

In draft recommendation, task force says evidence is insufficient for assessing benefits and harms of mammography for those aged 75 years and older, women with dense breasts.

Women with higher-than-average breast cancer risk, especially Black and Ashkenazi Jewish women, should start screening at younger age.

Researchers sought to determine if a cardiotoxicity management strategy could allow women with HER2-positive breast cancer to complete trastuzumab therapy.

Significant reduction seen in disease recurrence and mortality for those with highest versus lowest lifestyle index scores.

Interrupting adjuvant endocrine therapy to attempt pregnancy does not increase the risk of breast cancer recurrence, a study suggests.

Most performance measures higher for DBT than digital mammography performance benchmarks.

A prospective study compared the accuracy, sensitivity, and specificity of PET/CT with bone scintigraphy for the detection of metastasis in patients with breast cancer.

Estimated five-year cumulative incidence of local recurrence 3.1 percent for women undergoing BCT and adjuvant radiation.